Changes in retinoblastoma gene expression during cervical cancer progression

International Journal of Experimental Pathology

Volumn 83, Issue 6, 2002, Pages 275-286

  Salcedo, Mauricio ^a   Taja, Lucía ^c   Utrera, Dolores ^a   Chávez, Pedro ^b   Hidalgo, Alfredo ^a   Pérez, Carlos ^a   Benítez, Luis ^a   Castañeda, Cristina ^b   Delgado, Ricardo ^c   Gariglio, Patricio ^b  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

HPV; Invasive; Neoplasia; Retinoblastoma; Uterine cervix

Indexed keywords

MYC PROTEIN;

ARTICLE; CANCER GROWTH; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RETINOBLASTOMA; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA;

EID: 0036971402     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2002.00198.x     Document Type: Article

References (54)

1. ADNANE J. & ROBBINS P.D. (1995) The retinoblastoma susceptibility gene product regulates myc-mediated transcription. Oncogene 10, 381-387.
2. AMORTEGUI A.J., MEYER M.P., ELBORNE V.L. & AMIN R.M. (1995) P53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod. Pathol. 8, 907-912.
3. BEIJERSBERGEN R.L., HIJMANS E.M., ZHU L. & BERNARDS R. (1994) Interaction of C-Myc with the pRb-related protein p107 results in inhibition of C-Myc-mediated transactivation. EMBO J. 13, 4080-4086.
4. BENEDICT W.F., XU H.J., HU S.X. & TAKAHASHI R. (1990) The role of the retinoblastoma gene in initiation and progression of human cancer. J. Clin. Invest 85, 988-993.
5. BOYER S.N., WAZER D.E. & BAND V. (1996) E7 protein of Human Papilloma Virus-16 induces degradation of Retinoblastoma protein through the Ubiquitin-Proteasome pathway. Cancer Res. 56, 4620-4624.
6. CANCE W.G., BRENNAN M.F., DUDAS M.E., HUANG C.M. & CORDON-CARDO C. (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N. Engl. J. Med. 323, 1457-1462.
7. CHEN P.-L., RILEY D.J. & LEE W.-H. (1995) The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukaryot. Gene Expr. 5, 79-95.
8. CHOO K.B. & CHONG K.Y. (1993) Abscence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinoma. Virol. 193, 1042-1046.
9. CORDON-CARDO C. & WARTINGER D., PETRYLAK D. ET AL. (1992) Altered expression of the retinoblastoma gene product is prognostic indicator in bladder cancer. J. Natl. Cancer Inst. 84, 1251-1256.
10. CORDON-CARDO C. & RICHON V.M. (1994) Expression of the retinoblastoma protein is regulated in normal human tissues. Am. J. Pathol 144, 500-510.
11. DANG C.V. & LEE L.A. (1995) Structure of the c-myc gene and its transcription. In: C-Myc function in neoplasia. Medical Intelligence Unit. Georgetown, TX: R.G. Landes Company pp. 73-84.
12. DECAPRIO J.A., FURUKAWA Y., AJECHENBAUM F., GRIFFIN J.D. & LIVINGSTON D. (1992) The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci., USA 89, 1795-1798.
13. DYSON N., HOWLEY P.M., MÜNGER K. & HARLOW E. (1989) The human papillomavirus 16, E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
14. FRIEND S.H., HOROWITZ J.M., GERBER M.R. ET AL. (1987) Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc. Natl. Acad. Sci., USA 84, 9059-9063.
15. FURUKAWA Y., DECAPRIO J.A., BELVIN M. & GRIFFIN J.D. (1991) Heterogeneous expression of the product of the RB gene in primary human leukemia cells. Oncogene 6, 1343-1346.
16. GARIGLIO P., OCADIZ R. & SAUCEDA R. (1987) Human papillomavirus DNA sequences and C-myc oncogene alterations in uterine cervix carcinoma. Cancer Cells, Papillomavirus, CSH5, 343-348.
17. GARIGLIO P. & SALCEDO M. (1993) Molecular genetics of uterine cervix carcinoma. Involvement of C-myc oncogene. In: XVII World Congress of Anatomic and Clin. Pathol. (Ed: G. SANTOSCOY) pp. 295-300. Bologna, Italy: Monduzzi Editoire.
18. GERADTS J., HU S.X., LINCOLN C.E., BENEDICT W.F. & XU H.J. (1994) Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J. Cancer 58, 161-167.
19. GU W., BHATIA K., MAGRATH I.T., DANG C.V. & DALLA-FAVERA R. (1994) Binding and suppression of the Myc transcriptional activation domain by p107. Science 264, 251-254.
20. HARBOUR J.W., LAI S.L., WHANG P.J., GAZDAR A.F., MINNA J.D. & KAYE F.J. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241, 353-357.
21. HAMEL P., GILL R., PHILLIPS R. & GALLIE B. (1992) Transcriptional repression of the E2F-containing promoters E1aE, C-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol. 12, 3431-3438.
22. HANSON K.D., SHICHIRI M., FOLLANSBEE M.R. & SEDIVY J.M. (1994) Effect of C-myc expression on cell cycle progression. Mol Cell Biol. 14, 5748-5755.
23. HIDALGO A., SCHEWE C., PETERSEN S. ET AL. (2000) Human papillomavirus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J. Cancer 36, 542-548.
24. HOANG A.T., LUTTERBACK B., LEWIS B.C. ET AL. (1995) A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the C-Myc transactivation domain. Mol Cell Biol. 15, 4031-4042.
25. HOROWITZ J.M., PARK S.H., BOGENMANN E. ET AL. (1990) Frequent inactivation of the retinoblastoma antioncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci., USA 87, 2775-2779.
26. HUANG H.J., YEE J.K., SHEW J.Y. ET AL. (1988) Suppression of the neoplastic phenotype by replacement of the Rb gene in human cancer cells. Science 242, 1563-1566.
27. HU Q., LEES J.A., BUCHKOVICH K.J. & HARLOW E. (1992) The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol. 12, 971-980.
28. LAIMINS L.A. (1993) The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis. 2, 74-86.
29. LEE W.H., SHEW J.Y., HONG F.D. ET AL. (1987) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329, 642-645.
30. LIJ HU S.X., PERNG G.S., ZHOU Y. ET AL. (1996) Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene 13, 2397-2405.
31. LUDLOW J.W., GLENDENING C.L., LIVINGSTON D.M. & DECAPRIO J.A. (1993) Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol. 13, 367-372.
32. OCADIZ R., SAUCEDA R., CRUZ M., GRAEF A. & GARIGLIO P. (1987) High corrrelation between molecular alterations of the C-myc oncogene and uterine cervix carcinoma. Cancer Res. 47, 4173-4177.
33. PARKER M.F., ARROYO G.F., GERADTS J.B ET AL. (1997) Molecular characterization of adenocarcinoma of the cervix. Gynecol. Oncol. 64, 242-251.
34. PFISTER H. (1987) Human papillomavirus and genital cancer. Adv. Cancer Res. 48, 113-147.
35. RANGEL L.M., RAMIREZ M., TORROELLA M., PEDROZA A., IBARRA V. & GARIGLIO P. (1994) Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines. Arch. Med. Res. 25, 265-272.
36. RESNITZKY D. & REED S. (1995) Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell Biol. 15, 3463-3469.
37. RUSTGI A.K., DYSON N.J. & BERNARDS R. (1992) Amino-terminal domains of C-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 353, 541-544.
38. SALCEDO M., GARRIDO E., TAJA L. & GARIGLIO P. (1995) The retinoblastoma gene product negatively regulates cellular or viral oncogene promoters in vivo. Arch. Med. Res. 26, S157-S162.
39. SANO T., OYAMA T., KASHIWABARA K., FUKUDA T. & NAKAJIMA T. (1998) Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol. Int. 48, 580-585.
40. SCHEFFNER M., MUNGER K., BYRNE J.C. & HOWLEY P. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88, 5523-5527.
41. SHEW J.Y., LIN B.T., CHEN P.L., TSENG B.Y., YANG-FENG T.L. & LEE W.H. (1990) C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci., USA 87, 6-10.
42. SHIRODKAR S., EWEN M., DECAPRIO J.A., MORGAN J., LIVINGSTON D.M. & CHITTENDEN T. (1992) The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell 68, 157-166.
43. SOLINAS-TOLDO S., DÜRST M. & LICHTER P. (1997) Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc. Natl. Acad. Sci. USA 94, 3854-3859.
44. THOMAS R., EDWARDS M. & MARKS R. (1996) Translocation of the retinoblastoma gene product during mitosis. Exp Cell Res. 223, 227-232.
45. UZVOLGYI E., CLASSON M., HENRIKSSON M. ET AL. (1991) Reintroduction of a normal retinoblastoma gene in osteosarcoma cells inhibits the replication associated function of SV40 large T antigen. Cell Growth Differ. 2, 297-303.
46. VARLEY J.M., ARMOUR J., SWALLOW J.E. ET AL. (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4, 725-729.
47. WHYTE P., BUCHKOVICH K.J., HOROWITZ J.M. ET AL. (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A protein binds to the retinoblastoma gene product. Nature 334, 124-129.
48. WREDE D., TIDY J.A., CROOK T., LANE D. & VOUSDEN K.H. (1991) Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol. Carcinog. 4, 171-175.
49. XU H.J., HU S.X., CAGLE P.T., MOORE G.E. & BENEDICT W.F. (1991a) Abscence of retinoblastoma-protein expression in primary non-small cell lung carcinomas. Cancer Res. 51, 2735-2739.
50. XU H.J., HU S.X. & BENEDICT W.F. (1991b) Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene 6, 1139-1146.
51. YOSHIKAWA H., KAWANA T., KITAGAWA K., MIZUNO M., YOSHIKURA H. & IWAMOTO A. (1991a) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J. Cancer Res. 82, 524-531.
52. ISHIKAWA J., XU H.J., HU S.X. ET AL. (1991b) Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res. 51, 5733-5743.
53. ZACKSENHAUS E., BREMNER R., PHILLIPS R.A. & GALLIE B.L. (1993) A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol. 13, 4588-4599.
54. ZUR HAUSEN H. (1991) Viruses in human cancers. Science 254, 1167-1173.